Iron reduction by deferoxamine leads to amelioration of adiposity via the regulation of oxidative stress and inflammation in obese and type 2 diabetes KKAy mice. (Q53219528)
Jump to navigation
Jump to search
scientific article published on 13 September 2011
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Iron reduction by deferoxamine leads to amelioration of adiposity via the regulation of oxidative stress and inflammation in obese and type 2 diabetes KKAy mice. |
scientific article published on 13 September 2011 |
Statements
Iron reduction by deferoxamine leads to amelioration of adiposity via the regulation of oxidative stress and inflammation in obese and type 2 diabetes KKAy mice. (English)
1 reference
Soichiro Tajima
1 reference
Yasumasa Ikeda
1 reference
Kaori Sawada
1 reference
Noriko Yamano
1 reference
Yuya Horinouchi
1 reference
Yoshitaka Kihira
1 reference
Keisuke Ishizawa
1 reference
Yuki Izawa-Ishizawa
1 reference
Kazuyoshi Kawazoe
1 reference
Shuhei Tomita
1 reference
Kazuo Minakuchi
1 reference
Koichiro Tsuchiya
1 reference
Toshiaki Tamaki
1 reference
13 September 2011
1 reference
302
1 reference
E77-86
1 reference
1
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference